This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Merck: Managing Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109082-EStarting at €5.74
-
ATH Technologies (C)
Simons, Robert L.; Packard, JenniferCase HBS-117015-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
ATH Technologies (C) (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S05StrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
ATH Technologies (E)
Simons, Robert L.; Packard, JenniferCase HBS-117017-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: Managing Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109084-EStarting at €5.74
-
Merck: La administración de Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S04Knowledge and CommunicationStarting at €5.74
-
ATH Technologies (E) (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S07StrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: La administración de Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S06Knowledge and CommunicationStarting at €5.74
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20
-
Bausch & Lomb, Inc.: Presión para conseguir resultados
Simons, Robert L.; Sapir, Alex C.; Reinbergs, IndraCase HBS-105S08Accounting and ControlBausch & Lomb es objeto de ataques de la prensa y experimenta una fuerte caída de los precios de las acciones cuando se exponen las prácticas de gestión. la fijación de objetivos agresivo, apoyado por las expectativas del mercado financiero, se discute como un precursor de una serie de eventos que se traduce en resultados financieros representados incorrectamente y clientes enojados. Un CEO desafiante se mantiene firme como accionistas exigen su ...Starting at €8.20